Clinical Trial Update: Neoadjuvant Nivolumab and Chemotherapy in Patients With Localized Triple-negative Breast Cancer [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update reporting results for neoadjuvant nivolumab in combination with chemotherapy for localized triple-negative breast cancer (Phase 1/Phase 2)…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Triple-negative Breast Cancer

Drugs mentioned

• nivolumab (Opdivo) (nivolumab)

Snippet

Sponsor: Washington University School of Medicine | Conditions: Triple Negative Breast Cancer | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2024-05-16